1. Regulating impurities in pharmaceutical products: a tolerability of risk approach;Bouder;Expert Rev. Clin. Pharmacol.,2008
2. Q3A (R2): Impurities in New Drug Substances;ICH,2006
3. Q3B (R2): Impurities in New Drug Products;ICH,2006
4. Q3 C (R5): Impurities Guideline for Residual Solvents;ICH,2011
5. Guideline on the Limits of Genotoxic Impurities;Committee for Medicinal Products for Human Use (CHMP),2006